Biocryst Pharmaceuticals reported $-58801000 in Net Income for its third fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Net Income Change
Adamas Pharmaceuticals ADMS:US -19518000 7.17M
Alexion Pharmaceuticals ALXN:US $ 636M 100.2M
Alnylam Pharmaceuticals ALNY:US $ -204.51M 14.96M
Biocryst Pharmaceuticals BCRX:US $ -58.8M 15.6M
Chemocentryx CCXI:US $ -22.31M 16.9M
Chugai Pharma 4519:JP Y 86017M 15291M
Daiichi Sankyo 4568:JP Y 27246M 7974M
Gilead Sciences GILD:US $ 2592M 1070M
Glaxosmithkline GSK:US $ 1168M 227M
GlaxoSmithKline GSK:LN 1168M 227M
Intra Cellular Therapies ITCI:US $ -76.91M 8.16M
IONIS PHARMACEUT IONS:US $ -82M 1.12M
Karyopharm Therapeutics KPTI:US $ -51812000 1.77M
Mirati Therapeutics MRTX:US $ -80.05M 86.38M
Neurocrine Biosciences NBIX:US $ 22.5M 19.8M
Novavax NVAX:US $ -322.43M 29.89M
Ptc Therapeutics PTCT:US $ -133.62M 15.25M
Regeneron Pharmaceuticals REGN:US $ 1632.2M 1466.7M
Sarepta Therapeutics SRPT:US $ -48.14M 33.26M
Ultragenyx Pharmaceutical RARE:US $ -73M 49.43M
Vertex Pharmaceuticals VRTX:US $ 851.93M 785M
YTE INCY:US $ 181.74M 32.28M
Zogenix ZGNX:US $ -58M 0.89M